Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 305.4036
- Book/Share 61.2567
- PB 1.2335
- Debt/Equity 1.0691
- CurrentRatio 0.8034
- ROIC 0.0353
- MktCap 95619125411.0
- FreeCF/Share 3.7757
- PFCF 20.004
- PE 21.0646
- Debt/Assets 0.3202
- DivYield 0.0353
- ROE 0.0595
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
CVS Stock Approaches Q4 Earnings With Resistance In Sight
Published: February 11, 2025 by: Benzinga
Sentiment: Neutral
CVS Health Corp CVS will be reporting its fourth-quarter earnings on Wednesday. Wall Street expects 94 cents in EPS and $97.20 billion in revenues as the company reports before market hours.
Read More
What's a Fair Price for CVS Stock?
Published: February 11, 2025 by: The Motley Fool
Sentiment: Neutral
CVS (CVS 1.23%) is struggling to stay relevant amid rising costs and declining customer visits.
Read More
Dividend Roundup: Why CVS Health Is Still Better Than Walgreens
Published: February 10, 2025 by: Seeking Alpha
Sentiment: Negative
Investors drawn to WBA and CVS must feel disappointed. WBA's recent dividend suspension and CVS's dividend freeze reflect financial headwinds and operational challenges. I won't consider either as a buy candidate.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner CEBS
- Employees 219000